https://it.marketscreener.com/quotazioni/azione/TIZIANA-LIFE-SCIENCES-LTD-128528512/attualita/Tiziana-Life-Sciences-Ltd-avvia-uno-studio-clinico-multicentrico-di-Fase-2a-sul-Foralumab-intranasa-44942716/?utm_source=telegram&utm_medium=social&utm_campaign=share